Finance Watch: Two Years Later, $212m More Cash For Omega’s New Life Science Fund
VC Firm Raised $650m, Up From $438m In 2019
Private Company Edition: Omega Funds closed its seventh venture capital fund, far exceeding its $500m goal. Also, Anaveon raised a CHF110m ($119.8m) series B round, Ambys brought its series A total to $107m with $47m in additional investment and Mythic launched with a $103m series B round.
